CARLOS JESUS
DUEÑAS GUTIERREZ
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Hospital Universitario Pío del Río Hortega
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Pío del Río Hortega (6)
2023
-
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic
Viruses, Vol. 15, Núm. 2
-
Impact of COVID-19 on Adherence to Treatment in Patients with HIV
Healthcare (Switzerland), Vol. 11, Núm. 9
2022
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
2021
-
Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection
Journal of Personalized Medicine, Vol. 11, Núm. 7
2019
-
Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain
Frontiers in Microbiology, Vol. 10, Núm. APR
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092